HausenZur H. Papillomaviruses in anogenital cancer as a model to understanding the role of viruses in human cancers. Cancer Res1989; 49: 4677–81
2.
Jochmus-KudielkaISchneiderABraunR, et al.Antibodies against the human papillomavirus type 16 early proteins in human sera: Correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst1989; 81: 1698–1704
3.
WernessBALevineAJHowleyPM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science1990; 248: 76–9
4.
KinlenLJSheilAGRPetoJDollR. Collaborative United Kingdom Australasian study of cancer in patients treated with immunosuppressive drugs. BMJ1979; ii: 1461–6
5.
OrthG. Epidermodysplasia verruciformis. In: SalzmanNPHowleyPM, eds. The Papovaviridae. The papillomaviruses. New York: Plenum, 199–243
6.
RudlingerRSmithIWBunneyMHHunterJAA. Human papilloma virus infections in a group of renal transplant recipients. Br J Dermatol1986; 115: 681–92
7.
BarrBBBBentonECMcLarenK, et al.Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet1989; i: 124–9
8.
StegerGOlszewskuMStockflethEPfisterH. Prevalence of antibodies to human papillomavirus type 8 in human sera. J Virol1990; 64: 4399–406
9.
Cancer statistics: registration, England and Wales 1984. HMSO, London1988; Scottish Health Statistics 1986/7; Statistics and Research Bulletin, SRI/87 DHSS Belfast 1988. (Taken from report, Cancer Research Campaign, 1989)
10.
ZengYOuB. Etiology and pathogenesis of nasopharyngeal carcinoma. China: The People's Publishing House, 1985
11.
de TheG. Role of Epstein-Barr virus in human diseases: Infectious mononucleosis, Burkitt's lymphoma, and nasopharyngeal carcinoma. In: KleinG, ed. Viral oncology. New York: Raven Press, 1980: 769–97
12.
OldLJBoyseEAOettegenHF, et al.Precipitation antibody in human serum to an antigen present in cultured Burkitt's lymphoma cells. Proc Natl Acad Sci USA1966; 56: 1699–704
13.
HuangDPHoJHCSawDTeohTB. Carcinoma of the nasal and paranasal regions in rats fed Cantonese salted marine fish. In: de TheGItoY, eds. Nasopharyngeal carcinoma; etiology and Control. Lyon: IARC, 1978: 315–18
14.
GriffinBKarranL. Immortalization of monkey epithelial cells by specific fragments of Epstein-Barr virus DNA. Nature1984; 309: 78–82
15.
KarranLTeoCGKingD, et al.Establishment of immortalized primate epithelial cells with sub-genomic EBV DNA. Int J Cancer1990; 45: 763–72
HittMMAlldayMJHaraTKarranLJonesMDBussonsPTurszTErnbergIGriffinBE. EBV gene expression in an NPC-related tumour. EMBO J1989; 8: 2639–51
18.
ZengYShenSJDengH, et al.Early nasopharyngeal carcinoma among IgA/VCA antibody positive individuals detected by anti-complement immunoenzymatic medicine. Chinese Med J1984; 97: 155–7
19.
ShamJSTWeiWZongY-S, et al.Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy. Lancet1990; 335: 371–3
20.
KleinG. Viral latency and transformation: The strategy of Epstein-Barr virus. Cell1989; 58: 5–8
21.
KleinG. Multiple phenotypic consequences of the Ig/myc translocation in B-cell-derived tumors. Genes, Chromosomes Cancer1989; 1: 3–8
22.
DejeanABougueleretLCrzeschikKHTiollaisP. Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature1986; 322: 70–2
23.
WangJChenivesseXHengleinBBrechotC. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature1990; 343: 555–7
24.
WollersheimMDebelkaUHofschneiderPH. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene1988; 3: 545–54
25.
KekuleASLauerUMeyerMCaselmanWHHofschneiderPHKoshyR. The pre S2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature1990; 342: 457–61
26.
ChisariFVKlopchinKMoriyamaT, et al.Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell1989; 59: 1145–56
27.
HsuTYMoroyTEtiembleJ, et al.Activation of c-myc by Woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell1988; 55: 627–35
28.
FourelGTrepoCBougueleretL, et al.Frequent activation of N-myc genes of hepadnavirus insertion in woodchuck liver tumours. Nature1990; 347: 294–8
29.
NeilJCFultonRRigbyMStewartM. Evolution of pathogenic and oncogenic variants of feline leukaemia virus. Curr Top Microbiol Immunol1991, in press
30.
StewartMAWarnockMWheelerA, et al.Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J Virol1986; 58: 825–34
31.
FultonRPlumbMShieldLNeilJC. Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukaemia virus. J Virol1990; 64: 1675–82
32.
OnionsDLeesGForrestDNeilJC. Recombinant feline viruses containing the myc gene rapidly produce clonal tumours expressing T-cell antigen receptor gene transcripts. Int J Cancer1987; 40: 40–5
33.
FultonRForrestDMcFarlaneROnionsDNeilJC. Retroviral transduction of T-cell antigen receptor B-chain and myc genes. Nature1987; 326: 190–4
34.
BeralVPetermanTABerkelmanRJaffeHW. Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection?Lancet1990; 335: 123–8
35.
BeralVBullDJaffeHEvansBGillNTillettHSwerdlowAJ. Is risk of Kaposi's sarcoma in AIDS patients in Britain increased if sexual partners come from United States or Africa?BMJ1991; 302: 624–5